论文部分内容阅读
目的探讨参苓胃消胶囊联合多潘立酮治疗功能性消化不良的临床疗效。方法选取2013年12月—2014年11月攀枝花市仁和区仁和医院收治的功能性消化不良患者106例,按随机数字表法将其分为对照组与观察组,各53例。对照组患者予以多潘立酮治疗,观察组患者在对照组基础上加用参苓胃消胶囊治疗。观察两组患者临床疗效及不良反应发生情况。结果观察组患者总有效率高于对照组,差异有统计学意义(P<0.05);两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论参苓胃消胶囊联合多潘立酮治疗功能性消化不良的临床疗效显著,且不良反应小。
Objective To investigate the clinical effect of Shenling Weixiao capsule combined with domperidone in the treatment of functional dyspepsia. Methods From December 2013 to November 2014, 106 patients with functional dyspepsia admitted to Renhe Hospital, Renhe District, Panzhihua City were divided into control group and observation group according to random number table method, with 53 cases in each group. The patients in the control group were treated with domperidone. The patients in the observation group were treated with Shenlingweixiao Capsule on the basis of the control group. The clinical efficacy and adverse reactions of the two groups were observed. Results The total effective rate of observation group was higher than that of control group, the difference was statistically significant (P <0.05). There was no significant difference between the two groups in the incidence of adverse reactions (P> 0.05). Conclusion Shenling Weixiao Capsules combined with domperidone in the treatment of functional dyspepsia clinical significant effect, and adverse reactions.